178 related articles for article (PubMed ID: 38043489)
1. Exploring the potential of histone demethylase inhibition in multi-therapeutic approaches for cancer treatment.
Li D; Liang H; Wei Y; Xiao H; Peng X; Pan W
Eur J Med Chem; 2024 Jan; 264():115999. PubMed ID: 38043489
[TBL] [Abstract][Full Text] [Related]
2. Development of JmjC-domain-containing histone demethylase (KDM2-7) inhibitors for cancer therapy.
Zhang L; Chen Y; Li Z; Lin C; Zhang T; Wang G
Drug Discov Today; 2023 May; 28(5):103519. PubMed ID: 36754142
[TBL] [Abstract][Full Text] [Related]
3. Combination Therapy and Dual-Target Inhibitors Based on LSD1: New Emerging Tools in Cancer Therapy.
Shen L; Wang B; Wang SP; Ji SK; Fu MJ; Wang SW; Hou WQ; Dai XJ; Liu HM
J Med Chem; 2024 Jan; 67(2):922-951. PubMed ID: 38214982
[TBL] [Abstract][Full Text] [Related]
4. A comprehensive review of lysine-specific demethylase 1 and its roles in cancer.
Hosseini A; Minucci S
Epigenomics; 2017 Aug; 9(8):1123-1142. PubMed ID: 28699367
[TBL] [Abstract][Full Text] [Related]
5. Annual review of LSD1/KDM1A inhibitors in 2020.
Fu DJ; Li J; Yu B
Eur J Med Chem; 2021 Mar; 214():113254. PubMed ID: 33581557
[TBL] [Abstract][Full Text] [Related]
6. LSD1 Histone Demethylase Assays and Inhibition.
Hayward D; Cole PA
Methods Enzymol; 2016; 573():261-78. PubMed ID: 27372757
[TBL] [Abstract][Full Text] [Related]
7. Targeting LSD1 for acute myeloid leukemia (AML) treatment.
Zhang S; Liu M; Yao Y; Yu B; Liu H
Pharmacol Res; 2021 Feb; 164():105335. PubMed ID: 33285227
[TBL] [Abstract][Full Text] [Related]
8. Targeting the LSD1/KDM1 Family of Lysine Demethylases in Cancer and Other Human Diseases.
Mao F; Shi YG
Adv Exp Med Biol; 2023; 1433():15-49. PubMed ID: 37751134
[TBL] [Abstract][Full Text] [Related]
9. Recent Progress in Histone Demethylase Inhibitors.
McAllister TE; England KS; Hopkinson RJ; Brennan PE; Kawamura A; Schofield CJ
J Med Chem; 2016 Feb; 59(4):1308-29. PubMed ID: 26710088
[TBL] [Abstract][Full Text] [Related]
10. Promising natural lysine specific demethylase 1 inhibitors for cancer treatment: advances and outlooks.
Li ZR; Gu MZ; Xu X; Zhang JH; Zhang HL; Han C
Chin J Nat Med; 2022 Apr; 20(4):241-257. PubMed ID: 35487595
[TBL] [Abstract][Full Text] [Related]
11. Drug discovery of histone lysine demethylases (KDMs) inhibitors (progress from 2018 to present).
He X; Zhang H; Zhang Y; Ye Y; Wang S; Bai R; Xie T; Ye XY
Eur J Med Chem; 2022 Mar; 231():114143. PubMed ID: 35101649
[TBL] [Abstract][Full Text] [Related]
12. Targeting histone demethylases as a potential cancer therapy (Review).
Diao W; Zheng J; Li Y; Wang J; Xu S
Int J Oncol; 2022 Sep; 61(3):. PubMed ID: 35801593
[TBL] [Abstract][Full Text] [Related]
13. Targeting histone lysine demethylases - progress, challenges, and the future.
Thinnes CC; England KS; Kawamura A; Chowdhury R; Schofield CJ; Hopkinson RJ
Biochim Biophys Acta; 2014 Dec; 1839(12):1416-32. PubMed ID: 24859458
[TBL] [Abstract][Full Text] [Related]
14. Research progress of LSD1-based dual-target agents for cancer therapy.
Yang X
Bioorg Med Chem; 2024 Mar; 101():117651. PubMed ID: 38401457
[TBL] [Abstract][Full Text] [Related]
15. Expression, Purification, and Biochemical Analysis of the LSD1/KDM1A Histone Demethylase.
Laurent B; Shi Y
Methods Enzymol; 2016; 573():241-59. PubMed ID: 27372756
[TBL] [Abstract][Full Text] [Related]
16. Histone Lysine Demethylase Inhibitors.
Jambhekar A; Anastas JN; Shi Y
Cold Spring Harb Perspect Med; 2017 Jan; 7(1):. PubMed ID: 28049654
[TBL] [Abstract][Full Text] [Related]
17. Lysine-Specific Demethylase 1 Promises to Be a Novel Target in Cancer Drug Resistance: Therapeutic Implications.
Yang FF; Xu XL; Hu T; Liu JQ; Zhou JZ; Ma LY; Liu HM
J Med Chem; 2023 Apr; 66(7):4275-4293. PubMed ID: 37014989
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis and biological evaluation of novel dual-acting modulators targeting both estrogen receptor α (ERα) and lysine-specific demethylase 1 (LSD1) for treatment of breast cancer.
He M; Ning W; Hu Z; Huang J; Dong C; Zhou HB
Eur J Med Chem; 2020 Jun; 195():112281. PubMed ID: 32283297
[TBL] [Abstract][Full Text] [Related]
19. Structure-based design and discovery of potent and selective lysine-specific demethylase 1 (LSD1) inhibitors.
Nie Z; Shi L; Lai C; Severin C; Xu J; Del Rosario JR; Stansfield RK; Cho RW; Kanouni T; Veal JM; Stafford JA; Chen YK
Bioorg Med Chem Lett; 2019 Jan; 29(1):103-106. PubMed ID: 30409536
[TBL] [Abstract][Full Text] [Related]
20. Lysine-specific histone demethylase 1 (LSD1): A potential molecular target for tumor therapy.
Chen Y; Jie W; Yan W; Zhou K; Xiao Y
Crit Rev Eukaryot Gene Expr; 2012; 22(1):53-9. PubMed ID: 22339659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
